Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (231-240 of 991) with videos related to

Pageof 100
Sort By:
Diabetes Care|February 26, 2015
Blood pressure reduction: an added benefit of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetesColleen Majewski, George L Bakris
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The evolution of "pillars of therapy" to reduce heart failure risk and slow diabetic kidney disease progressionOlivia Blazek, George L Bakris
The Canadian Journal of Cardiology|January 16, 2022
Identifying Resistant Hypertension in the Population: The Devil Is in the DetailsVincent D Salvador, George L Bakris
European Heart Journal|March 30, 2011
Renal function and target organ damage in hypertensionLuis M Ruilope, George L Bakris
Current Opinion in Nephrology and Hypertension|June 30, 2009
Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?Rigas G Kalaitzidis, George L Bakris
Journal of the American College of Cardiology|June 8, 2019
Assessing Wide Pulse Pressure Hypertension: Data Beyond the GuidelinesGeorge L Bakris, Luke J Laffin
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathyJ P Lash, G L Bakris
American Journal of Hypertension|December 1, 1996
Salt intake and reductions in arterial pressure and proteinuria. Is there a direct link?G L Bakris, M R Weir
Current Opinion in Nephrology and Hypertension|June 12, 2010
Fixed-dose combination and chronic kidney disease progression: which is the best?Keith A Hopkins, George L Bakris
American Journal of Nephrology|April 24, 2010
Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Matthew R Weir, George L Bakris
Pageof 100

Showing results (231-240 of 991) with videos related to

Sort By:
Pageof 100
Diabetes Care|February 26, 2015
Blood pressure reduction: an added benefit of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetesColleen Majewski, George L Bakris
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The evolution of "pillars of therapy" to reduce heart failure risk and slow diabetic kidney disease progressionOlivia Blazek, George L Bakris
The Canadian Journal of Cardiology|January 16, 2022
Identifying Resistant Hypertension in the Population: The Devil Is in the DetailsVincent D Salvador, George L Bakris
European Heart Journal|March 30, 2011
Renal function and target organ damage in hypertensionLuis M Ruilope, George L Bakris
Current Opinion in Nephrology and Hypertension|June 30, 2009
Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?Rigas G Kalaitzidis, George L Bakris
Journal of the American College of Cardiology|June 8, 2019
Assessing Wide Pulse Pressure Hypertension: Data Beyond the GuidelinesGeorge L Bakris, Luke J Laffin
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathyJ P Lash, G L Bakris
American Journal of Hypertension|December 1, 1996
Salt intake and reductions in arterial pressure and proteinuria. Is there a direct link?G L Bakris, M R Weir
Current Opinion in Nephrology and Hypertension|June 12, 2010
Fixed-dose combination and chronic kidney disease progression: which is the best?Keith A Hopkins, George L Bakris
American Journal of Nephrology|April 24, 2010
Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Matthew R Weir, George L Bakris
Pageof 100